Association Between Metformin and Other Diabetic Medications and Five-year Onset of New Neovascular Age-related Macular Degeneration Diagnosis
Metformin may reduce the 5-year odds of developing nAMD, particularly in diabetic patients without diabetic retinopathy.
Authors
- John Moir (ORCID: https://orcid.org/0000-0001-9585-6028)
- Seenu M. Hariprasad (ORCID: https://orcid.org/0000-0003-0985-9551)
- Sean Smith
- Reem Gonnah
- Dimitra Skondra (ORCID: https://orcid.org/0000-0003-3862-6159)
- Arjav Shah
- Madeleine Yehia
- Max J. Hyman
- Andrea Flores
- Christopher M. Maatouk
Institutions
- Cleveland Clinic (US)
- Chicago Department of Public Health (US)
- University of Chicago (US)
- NYU Langone Health (US)
- Cleveland Eye Clinic (US)
Publication Details
- Journal
- Ophthalmic surgery, lasers & imaging retina
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3928/23258160-20251110-01
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00